CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Apeloa Pharmaceutical Co Ltd Company Snapshot
Apeloa Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Apeloa Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Northeast Pharmaceutical Group Co., Ltd. (2020 sales of 7.38 billion Chinese Renmimbi [US$1.15 billion] of which 55% was Pharmaceutical Products), KPC Pharmaceuticals Inc (7.72 billion Chinese Renmimbi [US$1.20 billion] of which 48% was Drugs Wholesale and Retail), and Zhejiang Medicine Co., Ltd. (7.33 billion Chinese Renmimbi [US$1.14 billion] of which 69% was Domestic).

Sales Analysis. During the first quarter of 2021, sales at Apeloa Pharmaceutical Co Ltd totalled 1.95 billion Chinese Renmimbi. This is an increase of 14.8% from the 1.70 billion Chinese Renmimbi in sales at the company during the first quarter of 2020. Apeloa Pharmaceutical Co Ltd reported sales of 7.88 billion Chinese Renmimbi (US$1.23 billion) for the year ending December of 2020. This represents an increase of 9.3% versus 2019, when the company's sales were 7.21 billion Chinese Renmimbi. Sales at Apeloa Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 82%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 123.4% in 2020, from 12.57 million Chinese Renmimbi to 28.09 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Apeloa Pharmaceutical Co Ltd
  Stock Performance Chart for Apeloa Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 25.60
(Figures in Chinese Renmimbi)
1 Week -3.7%   13 Weeks -10.7%  
4 Weeks -2.7%   52 Weeks 15.8%  
 
Apeloa Pharmaceutical Co Ltd Key Data:
  Ticker: 000739 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 7,879,672,743
(Year Ending Jan 2021).
Employees: 5,868
  Currency: Chinese Renmimbi Market Cap: 30,170,201,395
  Fiscal Yr Ends: December Shares Outstanding: 1,178,523,492
  Share Type: A Gu Closely Held Shares: 633,771,245
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.